Effect of Time-of-Day Administration of Amilodipine/Valsartan on Hypertention Control
Phase 3
Recruiting
- Conditions
- Stage II hypertension according to ACC/AHA2017 definition.Essential (primary) hypertension
- Registration Number
- IRCT20240131060872N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Age range between 35-75
Absence of underlying disease such as no renal diseases, no diabetes mellitus, and no cardiovascular diseases
No previous history of hypertension treatment
Consent to enter the study
Exclusion Criteria
Having renal diseases
Having diabetes Mellitus
Having cardiovascular diseases including ischemic, non-ischemic, and heart failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method